Eric Bernicker
Houston Methodist · 163 works · 6,290 citations · h-index 28
Top works
- Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
- Cecil Textbook of Medicine
- Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors: Guideline From the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology
- Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors
- Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium
- Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors
- Osimertinib-Induced Cardiotoxicity
- Cecil Textbook of Medicine
- Unanticipated Diagnoses Found at Autopsy in an Urban Public Teaching Hospital
- Association of Convalescent Plasma Therapy With Survival in Patients With Hematologic Cancers and COVID-19
- Racial Disparities in COVID-19 Outcomes Among Black and White Patients With Cancer
- Case Report: Transverse Myelitis Associated With Epstein-Barr Virus Infection
- Osimertinib induced cardio-toxicity: A retrospective review of FDA adverse events reporting system (FAERS).
- Challenges to Biomarker Testing for PD-1/PD-L1 Checkpoint Inhibitors for Lung Cancer
- Immune Checkpoint Inhibitor-Related Adverse Cardiovascular Events in Patients With Lung Cancer
- Combined Blockade of Activating ERBB2 Mutations and ER Results in Synthetic Lethality of ER+/HER2 Mutant Breast Cancer
- A Systematic Framework to Rapidly Obtain Data on Patients with Cancer and COVID-19: CCC19 Governance, Protocol, and Quality Assurance
- Programmed Death Ligand-1 (PD-L1) Expression in Either Tumor Cells or Tumor-Infiltrating Immune Cells Correlates With Solid and High-Grade Lung Adenocarcinomas
- Hybrid Capture–Based Genomic Profiling of Circulating Tumor DNA from Patients with Advanced Non–Small Cell Lung Cancer
- Practice Patterns and Outcomes in Elderly Stage I Non–Small-cell Lung Cancer: A 2004 to 2012 SEER Analysis